We’re excited to officially launch Jupiter Bioventures, a pioneering biotechnology venture foundry building bold, science-driven therapeutics companies. Co-Founders Nathaniel David, PhD, and Norman Sharpless, MD, bring decades of industry experience to drive a scalable foundry model, advancing #biotech innovation in #cancer and other areas in which insights from cancer biology provide insight. With $70 million raised from returning investors Mission BioCapital and Mayo Clinic alongside #lifescience investors Alexandria Venture Investments, Bioventure Partners, Cedars-Sinai Intellectual Property Company, CU Healthcare Innovation Fund, Eric Ball, Eshelman Ventures, LLC, Fox Ventures, The Brent and Julie Callinicos Trust and Vault Fund, Jupiter will found, launch, and operate multiple therapeutics companies. https://lnkd.in/eaUJsaE8 Stay tuned as we pursue breakthrough science to deliver #innovation in life sciences.
About us
Jupiter Bioventures is a biotechnology venture foundry, creating high-potential, high-return startups with speed, efficiency and hands-on management. Jupiter’s biotech foundry model builds opportunities at scale by validating groundbreaking science quickly, economically producing de-risked venture-stage companies with therapeutic candidates. Partnering with world-leading scientists, Jupiter supports and manages a system of “moons”—its portfolio of start-up companies. The moons address pressing needs in cancer and related diseases. Jupiter’s managing directors are proven serial entrepreneurs with decades of expertise in company-building, successful exits and high-impact leadership. For more information, visit www.jupiter.bio.
- Website
-
http://www.jupiter.bio
External link for Jupiter Bioventures
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Type
- Privately Held